Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)

Recruiting N/A Interventional Study
Cancer Early Detection of Cancer Circulating Cell-free DNA
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 75
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
12,500 (estimated)
Sponsor
Guangzhou Burning Rock Dx Co., Ltd. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

PREVENT is a prospective, multicenter, interventional study evaluating the performance of the OverC multi-cancer detection blood test in asymptomatic individuals with cancer risk.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participants must be able to provide a written informed consent form * Participants must not have received any colonoscopy, abdominal MRI/CT, low-dose CT, or chest CT within 5 years before signing the informed consent form * Participants must be able to provide blood samples f…
Contacts

Shangli Cai

13811823843

shangli.cai@brbiotech.com

CONTACT